Lab Guidance
- Novel coronavirus (2019-nCoV) technical guidance: laboratory testing for 2019-nCoV in humans (WHO)
- Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for coronavirus disease 2019 (COVID-19) (CDC)
- Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) (CDC)
- Laboratory guidelines for detection and diagnosis COVID-19 infection (PAHO)
- COVID-19: guidance for sampling and for diagnostic laboratories (PHE)
- Policy for diagnostics testing for coronavirus disease-2019 during the Public Health Emergency (FDA)
- Diagnostic tools and virus: questions and answers (CDC)
- Disease commodity package - novel coronavirus (COVID-19) (WHO)
- Responding to the coronavirus disease (COVID-19) pandemic (APHL)
Diagnostics
- CDC diagnostic test for COVID-19 (CDC)
- Information for laboratories (CDC)
- FAQs on diagnostic testing for SARS-CoV-2 (FDA)
- How to obtain a nasopharyngeal swab specimen (NEJM, Apr 17, 2020)
- Research use only 2019-novel coronavirus (2019-nCoV) real-time RT-PCR primer and probe information (CDC)
- Testing in the US (CDC)
- Serology-based tests for COVID-19 (Johns Hopkins)
- PCR diagnostic testing for SARS-CoV-2 (Johns Hopkins fact sheet)
- Serology testing for COVID-19 (Johns Hopkins fact sheet)
- Coronavirus disease (COVID-19) R&D (WHO)
- Emergency Use Authorizations (FDA)